We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Heparin Guidance for Drug- and Devicemakers
FDA Finalizes Heparin Guidance for Drug- and Devicemakers
June 28, 2013
The FDA renewed its call for companies that use crude heparin to make drugs or heparin components for medical devices to test each incoming shipment for species origin and contaminants and offered up test methods as part of finalized guidance on the subject.